← Open Payments lookup

MARTIN ATTA: Open Payments

NPI 1811570005 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$449 in 21 payments from 6 companies in 2025. Trend: 2023 $142 · 2024 $133 · 2025 $449

Food & beverage: $449
CompanyPaymentsAmount
ABBVIE INC.8$142
E.R. Squibb & Sons, L.L.C.4$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$75
Otsuka America Pharmaceutical, Inc.3$75
Neurocrine BioSciences, Inc.1$39
Axsome Therapeutics, Inc.1$28

Products named: VRAYLAR, COBENFY, CAPLYTA, ABILIFY MAINTENA, INGREZZA, Auvelity, REXULTI.

Industry payments across MD — which companies pay providers there.